Loading
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Previous close
$214.4
+$3.64 · +1.73%
After-hours
$214.08
−$0.32 · -0.15%
Oct 9, 5:38 PM ET
Regular session · ET · Market data may be delayed.
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Day range
Current $214.4
52-week range
Current $214.4
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
92
Deep Value
Sentiment
63
Bullish
Risk
30
Moderate Risk
Momentum
41
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Day range
Current $214.4
52-week range
Current $214.4
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 5.94B USD | 5.46B USD | 5.14B USD | 4.54B USD | 4.22B USD |
| Cost of goods sold | 3.31B USD | 3.06B USD | 2.92B USD | 2.56B USD | 2.34B USD |
| Gross profit | 2.63B USD | 2.4B USD | 2.22B USD | 1.98B USD | 1.88B USD |
| Research and development | 112.9M USD | 107.65M USD | 103.68M USD | 98.48M USD | 86.66M USD |
| Selling, general, and administrative | 1.41B USD | 1.33B USD | 1.25B USD | 1.09B USD | 1.32B USD |
| Operating expenses | 1.52B USD | 1.54B USD | 1.38B USD | 1.19B USD | 1.41B USD |
| Interest income | 9.8M USD | 8.4M USD | 11.04M USD | — | 6.28M USD |
| Interest expense | 60.7M USD | 86.26M USD | 144.35M USD | 110.84M USD | 89.49M USD |
| Depreciation and amortization | 486.5M USD | 476.22M USD | 565.24M USD | 552.9M USD | 553.1M USD |
| Operating income | 1.1B USD | 866.64M USD | 836.12M USD | 791.1M USD | 477.82M USD |
| Net income | 785.1M USD | 614.64M USD | 378.24M USD | 107.03M USD | 243.89M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$271.33
26.55% upsideCash distributions grouped by calendar year; partial years are marked.
$2.40
2025 complete year+44.6% since 2021
2026 partial: $1.95
$1.66
2,021
$1.80
2,022
$1.98
2,023
$2.18
2,024
$2.40
2,025
$1.95
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 4, 2026 | $0.69Quarterly | Sep 4, 2026 | Sep 25, 2026 |
Dividend | Jun 8, 2026 | $0.63Quarterly | Jun 8, 2026 | Jun 26, 2026 |
Dividend | Feb 17, 2026 | $0.63Quarterly | Feb 17, 2026 | Mar 19, 2026 |
Dividend | Nov 18, 2025 | $0.63Quarterly | Nov 18, 2025 | Dec 18, 2025 |
Dividend | Sep 4, 2025 | $0.63Quarterly | Sep 4, 2025 | Sep 26, 2025 |
Dividend | Jun 10, 2025 | $0.57Quarterly | Jun 10, 2025 | Jun 26, 2025 |
Ex-dividend Sep 4, 2026
$0.69
Quarterly
Record Sep 4, 2026 · Payment Sep 25, 2026
Ex-dividend Jun 8, 2026
$0.63
Quarterly
Record Jun 8, 2026 · Payment Jun 26, 2026
Ex-dividend Feb 17, 2026
$0.63
Quarterly
Record Feb 17, 2026 · Payment Mar 19, 2026
Ex-dividend Nov 18, 2025
$0.63
Quarterly
Record Nov 18, 2025 · Payment Dec 18, 2025
Ex-dividend Sep 4, 2025
$0.63
Quarterly
Record Sep 4, 2025 · Payment Sep 26, 2025
Ex-dividend Jun 10, 2025
$0.57
Quarterly
Record Jun 10, 2025 · Payment Jun 26, 2025
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
